A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. (Q30377443)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. |
scientific article |
Statements
1 reference
A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. (English)
1 reference
1 reference
Hong Jin
1 reference
Ruth A Karron
1 reference
George Kemble
1 reference
Kawsar R Talaat
1 reference
Brian R Murphy
1 reference
Catherine J Luke
1 reference
Elaine W Lamirande
1 reference
Karen A Callahan
1 reference
Kathy L Coelingh
1 reference
Susan C DiLorenzo
1 reference
Grace L Chen
1 reference
1 reference
1 reference
Identifiers
1 reference